Literature DB >> 3040863

Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression.

W L Farrar, S W Evans, U R Rapp, J L Cleveland.   

Abstract

Elevation of intracellular cyclic adenosine 3':5' monophosphate (cAMP) inhibits interleukin 2 (IL-2)-stimulated proliferation of a murine cytotoxic cell clone, CT6. The effects of antiproliferative dosages of stable cAMP-derivative, 8-bromoadenosine 3':5'-monophosphate (8-Br-cAMP), on steady state mRNA expression stimulated by IL-2 was examined. IL-2 stimulated mRNA accumulation of three nuclear proto-oncogenes c-fos, c-myc, and c-myb. 8-Br-cAMP alone stimulated c-fos, c-myb, and IL-2 receptor mRNA accumulation as determined by Northern blot analysis. 8-Br-cAMP, however, markedly inhibited c-myc expression stimulated by IL-2. Furthermore, although c-fos and IL-2 receptor mRNA expression was potentiated by 8-Br-cAMP, suppression of protein synthesis was seen. We show that antiproliferative cAMP stimulates similar mRNA expression as does IL-2, with the exception of c-myc. Although a comparative stimulation of steady state mRNA accumulation of some genes occurs, cAMP may profoundly effect protein synthesis. cAMP, therefore, acts on multiple targets involved in the macromolecular events stimulated by IL-2.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040863

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Protein kinase A-dependent binding of a nuclear factor to the 21-base-pair repeat of the human T-cell leukemia virus type I long terminal repeat.

Authors:  H T Poteat; F Y Chen; P Kadison; J G Sodroski; W A Haseltine
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

2.  Stem cells for murine interstitial cells of cajal suppress cellular immunity and colitis via prostaglandin E2 secretion.

Authors:  Maneesh Dave; Yujiro Hayashi; Gabriella B Gajdos; Thomas C Smyrk; Phyllis A Svingen; Sergiy M Kvasha; Andrea Lorincz; Haidong Dong; William A Faubion; Tamas Ordog
Journal:  Gastroenterology       Date:  2015-01-28       Impact factor: 22.682

3.  Response of the human T-cell leukemia virus type 1 long terminal repeat to cyclic AMP.

Authors:  H T Poteat; P Kadison; K McGuire; L Park; R E Park; J G Sodroski; W A Haseltine
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

4.  Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus.

Authors:  P Hasler; L A Schultz; G M Kammer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

5.  Cyclic AMP--an intracellular second messenger for interleukin 1.

Authors:  F Shirakawa; U Yamashita; M Chedid; S B Mizel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Dibutyryl cyclic AMP inhibits the progression of experimental autoimmune encephalomyelitis and potentiates recruitment of endogenous neural stem cells.

Authors:  Shiva Khezri; Mohammad Javan; Mahdi Goudarzvand; Saeed Semnanian; Hossein Baharvand
Journal:  J Mol Neurosci       Date:  2013-01-19       Impact factor: 3.444

7.  Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids.

Authors:  D Santoli; P D Phillips; T L Colt; R B Zurier
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

8.  Protein kinase A-mediated phosphorylation of the T-cell surface antigen CD27.

Authors:  K Sugita; J D Dasgupta; Y Nojima; K Agematsu; S F Schlossman; C Morimoto
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

Review 9.  Prostaglandin E2 and T cells: friends or foes?

Authors:  Vinatha Sreeramkumar; Manuel Fresno; Natalia Cuesta
Journal:  Immunol Cell Biol       Date:  2011-09-27       Impact factor: 5.126

10.  Proinflammatory and immunoregulatory roles of eicosanoids in T cells.

Authors:  Anna Mari Lone; Kjetil Taskén
Journal:  Front Immunol       Date:  2013-06-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.